Accelerate IND Timelines with Charles River
Optimized IND-enabling programs now ensure 26-week (max) timelines from test article receipt to final reports
November 14, 2011 - We’re listening to the evolving needs and expectations of our clients. You said you wanted accelerated IND timelines, so Charles River has adopted new standardized reporting timelines to do just that. All Charles River preclinical facilities now offer a fully compiled audited draft report at 10 weeks post-necropsy for studies up to and including 13 weeks of treatment.
IND-enabling programs at Charles River are on accelerated timelines, where all required final reports are delivered at a maximum of 26 weeks from test article receipt (given standard program parameters). This includes allotted time for analytical and bioanalytical method development and validation, repeat-dose toxicology in-life and reversal phases (in this example with treatment up to 28 days with a 28-day recovery), and standard safety pharmacology battery and genetic toxicology tests.
For your IND guide and full access to our accelerated reporting timelines, including a Gantt chart, please log in to The Source℠. If you are not a member of The Source℠, our new online scientific and educational information center, please click here to register.
For more information about our preclinical capabilities, contact us at 1.877.CRIVER.1 (1.877.274.8371) or askcharlesriver@crl.com.
Related Information